Fig. 1. The distribution of the diseases shows that the most common reason resulted in intravenous bisphosphonate use was breast CA. (CA: cancer, SCC: squamous cell carcinoma)

J Korean Assoc Oral Maxillofac Surg 2023;49:68~74
https://doi.org/10.5125/jkaoms.2023.49.2.68

© JKAOMS